Loading...
High-Dose Cholera Vaccine Developed by UMSOM Scientists Shows Promise for Controlling Outbreaks
Authors
Advisor
Date
2017-12-11
Embargo until
Language
Book title
Publisher
Peer Reviewed
Type
Article
Research Area
Jurisdiction
Other Titles
See at
Abstract
Data Availibility
Data / Code Location
Table of Contents
Description
Description of a promising cholera vaccine resulting from a study conducted in Mali by the University of Maryland, Baltimore, School of Medicine's Center for Vaccine Development (CVD). The new single-dose, live-attenuated oral vaccine is licensed and manufactured by PaxVax under the name of Vaxchora.
Citations
Altmetric: